ICON Salt Lake City is a clinical research site located in Salt Lake City, Utah, United States 84124.
Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.
ICON Salt Lake City has participated in 11 clinical trials.
Therapeutic areas: Pain, Focal Segmental Glomerulosclerosis (FSGS), Alpha-1 Antitrypsin Deficiency.
Sponsors: Vertex Pharmaceuticals Incorporated.
Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
ICON Salt Lake City has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
ICON Salt Lake City has 11 clinical trials on record. Their work covers Pain, Focal Segmental Glomerulosclerosis (FSGS), Alpha-1 Antitrypsin Deficiency.
ICON Salt Lake City has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.